|
|
||||||||


,
* Wyle Laboratories and
National Aeronautics and Space Administration, Life Sciences Division, NASA Ames Research Center, Moffett Field, California 94035; and
U.S. Army Institute of Surgical Research, Fort Sam Houston, Texas 78234
1To whom requests for reprints should be addressed at Life Sciences Division, MS 239-11, NASA Ames Research Center, Moffett Field, CA 94035. E-mail: jtou{at}mail.arc.nasa.gov
| Abstract |
|---|
|
|
|---|
Key Words: ambulatory space flight calcium corticosterone estradiol
| Introduction |
|---|
|
|
|---|
Nonpurified diets are formulated from natural ingredients and contain multiple sources of nutrients. Bioavailability of nutrients in nonpurified diets may be reduced compared with purified diets due to nutrient interactions and losses during processing (6). Additionally, ingredient differences between purified and nonpurified diets may influence the outcome of bone studies. For example, many commercially available nonpurified rodent diets are high in phytoestrogens, which are plant-derived compounds capable of exerting estrogenic activity (7). Phytoestrogens present in soy have been reported to protect against bone loss in ovariectomized rats (8). The HLS of rats induces a decrease in sex steroids that may contribute to osteopenia and bone loss (9). The estrogenic activity associated with phytoestrogens may prevent some of the osteopenic changes in unweighted bones. Another potential mechanism for HLS-induced osteopenia is increased stress hormones (i.e., corticosterone). Phytoestrogen consumption has been reported to enhance stress responses (10). Therefore, it is important to understand the endocrine effects of diet on bone.
Previously, space flight experiments have been short (20 days) and consisted of young rats (11, 12). In a short-term (2-week) study, Zerath et al. (5) reported no difference (P < 0.05) in skeletal growth or bone changes induced by HLS of young adult male rats fed either the semipurified space flight diet or standard nonpurified rodent diet. Current space flight mission durations are increasing, and future experiments propose using animals of different ages and sex. We used young adult female rats to compare the effect of feeding a purified diet compared with a nonpurified diet on bone changes induced by long-term HLS to determine whether the diets can be used interchangeably.
| Materials and Methods |
|---|
|
|
|---|
Animals and Diet.
Virgin female Sprague-Dawley rats aged 50 days (n = 36) were received from Simonsen Laboratories (Gilroy, CA). On receipt, animals were individually housed in NASA-designed HLS cages (14) in a room maintained at 22° ± 2°C with a 12:12-hr light:dark cycle (0600 hrs lights-on and 1800 hrs lights-off). Rats were randomly assigned to be fed either the purified ingredient American Institute of Nutrition (AIN) 93G diet (TD 94045; Harlan Teklad, Madison, WI) or a nonpurified ingredient rodent diet (8728C; Harlan Teklad).
The semipurified diet (TD 97071; Harlan Teklad) currently used to feed rodents during space flight was not included in this study, because the nutritional adequacy of the space flight diet for use in long-term studies (>20 days) is not documented (4). The semipurified space flight diet is based on the formulation of the AIN-76 diet that contains some nutrients below current NRC recommended levels (4, 6). The AIN-93G diet conforms to the updated NRC nutritional recommendations for rat growth, maintenance, and reproduction (6, 15). The AIN-93 diets have been determined to be nutritionally adequate for long-term (13-week) animal studies and are widely used (16).
Purified diets are phytoestrogen free, whereas soy-based nonpurified diets contain varying levels of phytoestrogens (7). We selected the certified Harlan Teklad 8728C nonpurified diet that contained dietary phytoestrogens within the range found in other commercially available nonpurified rodent diets (7). Otherwise, the selected nonpurified diet conforms to the NRC nutritional recommendations for rat growth, maintenance, and reproduction (6). Table 1
lists some nutrients and their levels in the purified AIN-93G and nonpurified diets. Both diets were provided in powder form to facilitate measurement of food intake. Assigned diet and water were provided ad libitum throughout the study.
|
|
Bone Analysis.
The left femur, tibia, and humerus were collected. The bones were defleshed, with care being taken not to damage the periosteum. Each bone was wrapped in saline-soaked gauze and stored at 20°C until analyzed. For analysis, each bone was brought to room temperature and the bone lengths measured with a caliper.
Mechanical strength was determined in the femur by torsion testing using a technique developed at the NASA Ames Research Center (Moffett Field, CA). Principles are identical to torsion tests reported in the literature (18) except that a metal alloy was used for embedding the bones. For the torsion test, the ends of the bone were embedded in specially designed aluminum cups that contained a metal alloy that is liquid at 56°C and then hardens rapidly at 25°C. The metal cups fit precisely into a torsion instrument. The instrument applies uniform torque along the diaphysis of the bone, rotating the potted bone at 1° sec1 to failure. Fracture occurs at the weakest area of the exposed 10- to 14-mm test segment. The maximum torque was determined in the computer program from the torque-angular deformation data.
The tibia, humerus, and femur bone fragments were dried at 110°C (Oven DK-63; Baxter Scientific Products, Hayward, CA) for 48 hrs to determine dry weights. Bones were then ashed at 600°C in a muffle furnace (Furnatrol 1 model CP18210; Thermolyne, Dubuque, IA) for 1824 hrs. Bone mineral content (BMC) was determined by the weight of the bone ash.
Urinary Biochemical Analysis.
The NASA-designed HLS cage also functions as a metabolic cage (14). Urine samples were collected for 24 hrs to account for the diurnal variation in hormone levels. Urine volumes and samples were collected at the start of HLS and at the end of the 38-day experiment and changes expressed as
the difference in start-end levels. Clean funnels were used for each of the urine collection periods. Decalyne oil (1 ml) was added to the urine collection tubes to prevent evaporation. Collected 24-hr urine samples were centrifuged at 1,500 g for 10 mins at 4°C. Following centrifugation, urine samples were aliquoted into fresh tubes and kept frozen at 20°C until assayed. Urinary concentrations of creatinine and calcium were measured using an automated analytical spectrophotometer system (COBAS; Roche Diagnostic Systems, Somerville, NJ).
To monitor stress levels and adaptation, we collected urine samples at the start and end of HLS. Collection of 24-hr urine samples accounts for diurnal variations in corticosterone and bypasses the stress associated with obtaining multiple blood samples. Urinary corticosterone was determined according to Ortiz et al. (19). Briefly, aliquots of urine (250 µl) were extracted with 1:1 dichloromethane. Following extraction, urine samples were reconstituted 1:20 using steroid diluent, and urinary corticosterone levels were determined by the commercially available rat corticosterone ImmunChem double antibody radioimmunoassay kit (ICN Biomedicals, Costa Mesa, CA). Radioisotope counting was performed using a Cobra II Auto-Gamma counter (Packard BioScience, Downers Grove, IL). All samples were measured in duplicate. The intraassay and interassay coefficients of variation for urinary corticosterone were 3.6% and 4.3%, respectively.
Plasma Hormone Analysis.
Blood samples were obtained from the rats at dissection. Animals were anesthetized with isoflurane, bled by cardiac puncture, then decapitated. Blood was collected in ice-cold tubes that contained heparin. Collected blood samples were centrifuged at 1,500 g for 10 mins at 4°C to separate plasma. Plasma samples were collected and stored at 70°C until assayed for estradiol and corticosterone. A commercially available estradiol Coat-a-Count radioimmunoassay kit (Diagnostic Products Corporation, Los Angeles, CA) was used to measure plasma concentrations of estradiol. The intraassay and interassay coefficients of variation were 6.2% and 7.5%, respectively, for estradiol. A commercially available rat corticosterone ImmunChem double antibody radioimmunoassay kit (ICN Biomedicals) was used to determine plasma corticosterone levels. The intraassay and interassay coefficients of variation were 5.0% and 5.3%, respectively, for plasma corticosterone.
Statistical Analysis.
Urinary corticosterone and calcium excretion were calculated as follows: [urine]calcium or corticosterone x [24-hr volume] and corrected for creatinine. Correlations between bone mass and BMC, plasma estradiol and bone parameters, and plasma or urinary corticosterone and bone parameters were determined by a simple regression of individual animals. Two-way analysis of variance was used to determine differences due to diet, HLS treatment, or diet x HLS treatment. Post hoc multiple comparison tests were performed using the Tukey test. All statistical analyses were performed using StatView statistical software (Abacus Concepts, Berkeley, CA). Results are expressed as means ± SEM, and differences were considered statistically significant at P < 0.05.
| Results |
|---|
|
|
|---|
|
|
|
Bone Mineral Content.
The BMC of tibia and femur was reduced in HLS rats compared with ambulatory animals, indicating an unloading effect (P < 0.05). Femoral BMC was reduced by 8.6% and 11.4% in HLS rats fed a nonpurified diet and in the animals fed the AIN-93G diet, respectively. However, the effects of the AIN-93G diet compared with the nonpurified diet on BMC of unweighted bones were not statistically different. The humerus, normally weighted in the HLS model, showed no changes in either dry weight or BMC (Table 3
).
Mechanical Strength.
Compared with ambulatory controls, mechanical strength of the femur was decreased in HLS rats, indicating an unloading effect (P < 0.01). Femoral mechanical strength was decreased by 24% in the rats fed a nonpurified diet and by 31% in the animals fed the AIN-93G diet. The effects of the purified AIN-93G diet compared with the nonpurified diet on mechanical strength of unweighted bones were not statistically different. Mechanical strength of the femur correlated with its dry weight (r = 0.73, P < 0.05) and BMC (r = 0.74, P < 0.05) but not length.
Urinary Biochemical Analysis.
As a result of differences in urinary creatinine excretion, urinary calcium and corticosterone excretion are presented as 24-hr excretion and referenced to creatinine excretion (Table 4
).
|
the difference in start-end levels during HLS were insignificant.
Calcium.
Difference in calcium levels between the diets (Table 1
) resulted in rats fed the nonpurified diet having higher dietary calcium consumption than animals fed a purified AIN-93G diet (Table 2
). The ratio of dietary calcium to phosphorus for all treatment groups was greater than 1, with no differences among the treatment groups (Table 2
). Urinary calcium excretion was higher (P < 0.05) in rats fed a nonpurified diet compared with a purified AIN-93G diet, indicating a diet effect (P < 0.05) (Table 4
). Changes in urinary calcium determined by
the difference in start-end levels during HLS were insignificant.
Corticosterone.
Urinary corticosterone results were similar regardless of how values were expressed. Urinary corticosterone excretion was higher (P < 0.01) in groups fed a nonpurified diet compared with those fed a AIN-93G diet, indicating a diet effect (P < 0.05). Rats subjected to unloading and fed a nonpurified diet showed elevated urinary corticosterone excretion and a large change determined by
the difference in start-end urinary corticosterone compared with the animals fed the AIN-93G diet, indicating a significant (P < 0.05) diet x HLS effect (Table 4
).
Final urinary corticosterone excretion (r = 0.81, P < 0.01) and urinary corticosterone/creatinine (r = 0.81, P < 0.01) were inversely correlated to tibia dry weight. There was no relationship between urinary corticosterone excretion and femur or humerus bone parameters (i.e., dry weight, mechanical strength, BMC, or length).
Plasma Hormones Analysis.
Corticosterone.
Plasma corticosterone was inversely correlated to tibia dry weight (r = 0.75, P = 0.03) and BMC (r = 0.69, P < 0.05) but not to femur or humerus bone parameters (i.e., dry weight, mechanical strength, BMC, or length). There were no significant differences in adrenal mass, an indicator of chronic stress, among ambulatory rats fed the AIN-93G diet (62 ± 2 mg), ambulatory rats fed the nonpurified diet (58 ± 2 mg), HLS rats fed the AIN-93G diet (60 ± 1 mg), and HLS rats fed the nonpurified diet (61 ± 3 mg).
Estradiol.
The HLS rats showed prolonged diestrus, a phase associated with reduced plasma estradiol levels (17). Plasma estradiol levels were lower (P = 0.05) in the HLS rats fed the AIN-93G diet (7.2 ± 1.3 pg/ml) compared with the ambulatory rats fed the AIN-93G diet (18.8 ± 3.5 pg/ ml) but similar in the HLS rats fed the nonpurified diet (13.0 ± 1.9 pg/ml) and ambulatory rats fed the nonpurified diet (15.2 ± 3.8 pg/ml), indicating a unloading effect (P = 0.03). Plasma estradiol was correlated (r = 0.85, P < 0.01) with femur BMC but not femur dry mass, length, or mechanical strength. There were no correlations between plasma estradiol and bone parameters measured in the tibia and humerus. There was no relationship between plasma estradiol and plasma or urinary corticosterone levels.
| Discussion |
|---|
|
|
|---|
Studies have reported that HLS of aging (6-month-old) female rats fed a standard nonpurified rodent diet resulted in osteopenia (9, 23). In our study that used young adult (77-day-old) female rats, tibia BMC, dry weight, femoral dry weight, BMC, and mechanical strength were reduced by HLS compared with ambulatory animals (Table 3
). A positive correlation (r = 0.74, P = 0.03) between femur BMC and mechanical strength indicated that osteopenia following unloading increased the susceptibility of bone to fracture. Absence of similar bone changes in the humerus (Table 3
), which remained weight bearing in the HLS model, confirmed that osteopenic changes in bones of young female rats were due to unloading. Despite multiple nutrient differences, purified diets compared with nonpurified diets had no measurable difference on the osteopenia induced by unloading.
Still it is important to consider diet; the higher urinary creatinine excretion observed in rats fed a nonpurified diet compared with a purified AIN-93G diet (Table 4
) may have been due to higher protein intake. Higher urinary calcium excretion was likely due to the higher calcium content of the nonpurified diet (24). However, Globus et al. (25) found that high (2.44%) dietary calcium failed to alter the bone changes induced by HLS, suggesting that the calcium level used in this study may not have been sufficiently high for diet to interfere with BMC changes induced by HLS of rats (Table 1
).
Reduced sex steroid levels are another potential mechanism for the development of osteopenia in space flight rats. Space flight male rats have reduced testosterone levels (26, 27), but no data are available regarding the effects of space flight on estrogen levels in female rats. The HLS studies that used female rats observed no significant changes in plasma estradiol levels in rats (9, 23). In these studies, estrogen findings may have been confounded by feeding nonpurified diets that contained phytoestrogens, not controlling for hormonal fluctuations, and the tendency for aging rats to show large variability in their estrogen levels. In our study, plasma estradiol levels were low (P = 0.05) in HLS young adult rats fed a purified AIN-93G diet and euthanized in the same phase of the estrous cycle. The decrease in plasma estradiol levels induced by HLS in the purified but not the nonpurified diet may have occurred because of the dietary phytoestrogens acting as an estrogen agonist. The soy-based nonpurified diet contains phytoestrogen levels reported to exert endocrine changes (7) (Table 1
).
Kawano et al. (28) reported that ovariectomized female rats subjected to HLS and treated with intramuscular injection of 200 µg/g of estradiol dipropionate prevented reduction in femur mass and calcium content, suggesting that estradiol can protect against osteopenia induced by HLS. In our study, femoral BMC was correlated (r = 0.85, P < 0.01) to plasma estradiol. In HLS rats, femoral BMC was lower by 8.6% in rats fed a nonpurified diet and by 11.4% in animals fed the AIN-93G diet compared with ambulatory controls. Femur mechanical strength in HLS rats was lower by 24% in rats fed a nonpurified diet and by 31% in the animals fed a AIN-93G diet compared with ambulatory controls (Table 3
). The slight reduction in osteopenia in animals fed the nonpurified diet, although not statistically significant, may have been due to the phytoestrogens present in a nonpurified diet exerting estrogenic activity. Other measurements, such as histomorphometry, may be valuable for detecting estrogen and phytoestrogen effects on BMC in unloaded bones.
Another hormonal alteration with potential to affect bone changes induced by unloading is corticosterone, a hormone secreted by the adrenal gland in response to a stressor and known to be a contributing factor in osteoporosis. In our study, an inverse correlation between both urinary corticosterone excretion (r = 0.79, P < 0.01) and plasma corticosterone (r = 0.75, P = 0.03) to tibia dry weight suggests that corticosterone may be responsible for the bone changes in the HLS female rats. However, there was no relationship of corticosterone to femur or humerus BMC. The tibia may be more responsive than the other bones to the changes induced by HLS. Lafage-Proust et al. (29) examined the effect a 14-day space flight had on various bone sites and found early and major changes in the tibia, less marked and delayed changes in the humerus, and minor changes in the femur.
Halloran et al. (30) found no difference in the bone response to unloading in adrenalectomized and steroid-treated male rats. Zerath et al. (31) also observed no bone differences between adrenalectomized or steroid-treated male rats with corticosterone implants after a 17-day space flight. The data in male rats indicate that osteopenia induced by unloading was not related to corticosterone. Our data on female rats showed an inverse correlation of corticosterone to tibia BMC. Female rats have a higher and faster plasma corticosterone response to stressors than male rats (32). This is because estrogen plays a role in the stress response as evidenced by increased response to stress in ovariectomized (i.e., estrogen deficient) rats treated with estradiol (33). In male rats, lifelong consumption of high-phytoestrogen diets enhanced the stress response (10). In agreement, in this study female rats subjected to HLS and fed the phytoestrogen-containing nonpurified diet had elevated urinary corticosterone excretion. Absence of chronic stress was indicated by the absence of enlarged adrenal glands. Higher urinary corticosterone excretion in female rats fed phytoestrogen-containing nonpurified diets during the start of HLS may have contributed to the early decrease in growth that manifested as shortened bone length at the end of the study. In male rats, excess corticosterone has been shown to inhibit bone growth (34). Clearly, the role of phytoestrogens and corticosterone on bones requires further study.
In summary, the use of a nonpurified versus purified diet can influence the results of bone studies as indicated by diet-induced effect on longitudinal bone growth and other factors that have a role in bone metabolism, particularly, plasma estradiol and corticosterone. Diet-induced bone effects and nutrient differences did not interfere with the osteopenic changes induced by unloading. It is likely that measurable diet effects on unloaded bones were obscured by the severity of the osteopenia induced by unloading. The role of diet remains an important factor to consider not only in space flight studies of bone but in any experiment that measures bone end points.
| Acknowledgments |
|---|
| Footnotes |
|---|
Received for publication June 14, 2004. Accepted for publication October 11, 2004.
| References |
|---|
|
|
|---|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |